Ruzicka T et al. |
Tacrolimus: the drug for the turn of the millennium? |
1999 |
Arch Dermatol |
pmid:10328199
|
Qureshi AA and Fischer MA |
Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. |
2006 |
Arch Dermatol |
pmid:16702502
|
Jegasothy BV et al. |
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. |
1992 |
Arch Dermatol |
pmid:1376102
|
Van Leent EJ et al. |
Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. |
1998 |
Arch Dermatol |
pmid:9681343
|
Mandelin J et al. |
Effect of oral acetylsalicylic acid on burning caused by tacrolimus ointment in patients with atopic dermatitis. |
2010 |
Arch Dermatol |
pmid:20956662
|
Passeron T et al. |
Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. |
2004 |
Arch Dermatol |
pmid:15381545
|
Bunker CB et al. |
Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. |
2004 |
Arch Dermatol |
pmid:15381566
|
Ehst BD and Warshaw EM |
Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin. |
2004 |
Arch Dermatol |
pmid:15313828
|
Sagransky MJ et al. |
A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. |
2010 |
Arch Dermatol |
pmid:21173330
|
Eiling E et al. |
Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption. |
2008 |
Arch Dermatol |
pmid:18794482
|
Byrd JA et al. |
Response of oral lichen planus to topical tacrolimus in 37 patients. |
2004 |
Arch Dermatol |
pmid:15611431
|
Santos-Juanes J et al. |
Topical tacrolimus: an effective therapy for Zoon balanitis. |
2004 |
Arch Dermatol |
pmid:15611442
|
Milingou M et al. |
Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. |
2004 |
Arch Dermatol |
pmid:15611445
|
Yan AC et al. |
The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. |
2010 |
Arch Dermatol |
pmid:20083693
|
Ciurea AM et al. |
Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone. |
2010 |
Arch Dermatol |
pmid:20083712
|
Mikhail M et al. |
Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. |
2008 |
Arch Dermatol |
pmid:18427063
|
Böhm M et al. |
Successful treatment of anogenital lichen sclerosus with topical tacrolimus. |
2003 |
Arch Dermatol |
pmid:12873890
|
Reitamo S et al. |
Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. |
2000 |
Arch Dermatol |
pmid:10926735
|
Carroll PB et al. |
Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. |
1994 |
Arch Dermatol |
pmid:7526802
|
Allen DM and Esterly NB |
Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. |
2002 |
Arch Dermatol |
pmid:12225004
|
Okudaira H et al. |
Control of allergic diseases by regulation of cytokine gene transcription. |
1997 |
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M |
pmid:9383912
|
Pavan M et al. |
Polyomavirus associated nephropathy presenting five years after kidney transplantation. |
2011 |
Arab J Nephrol Transplant |
pmid:21999857
|
Barreiro C and MartÃnez-Castro M |
Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506). |
2014 |
Appl. Microbiol. Biotechnol. |
pmid:24272367
|
Salehi-Najafabadi Z et al. |
The gamma-butyrolactone receptors BulR1 and BulR2 of Streptomyces tsukubaensis: tacrolimus (FK506) and butyrolactone synthetases production control. |
2014 |
Appl. Microbiol. Biotechnol. |
pmid:24562179
|
Kimura T et al. |
N-glycosylation is involved in the sensitivity of Saccharomyces cerevisiae to HM-1 killer toxin secreted from Hansenula mrakii IFO 0895. |
1999 |
Appl. Microbiol. Biotechnol. |
pmid:10091323
|
Song K et al. |
Engineering of the LysR family transcriptional regulator FkbR1 and its target gene to improve ascomycin production. |
2017 |
Appl. Microbiol. Biotechnol. |
pmid:28349163
|
Mo S et al. |
Application of a combined approach involving classical random mutagenesis and metabolic engineering to enhance FK506 production in Streptomyces sp. RM7011. |
2013 |
Appl. Microbiol. Biotechnol. |
pmid:23053074
|
Wang J et al. |
Comparative proteomic and metabolomic analysis of Streptomyces tsukubaensis reveals the metabolic mechanism of FK506 overproduction by feeding soybean oil. |
2017 |
Appl. Microbiol. Biotechnol. |
pmid:28175948
|
Ordóñez-Robles M et al. |
Target genes of the Streptomyces tsukubaensis FkbN regulator include most of the tacrolimus biosynthesis genes, a phosphopantetheinyl transferase and other PKS genes. |
2016 |
Appl. Microbiol. Biotechnol. |
pmid:27357227
|
Salehi-Najafabadi Z et al. |
Characterisation of a γ-butyrolactone receptor of Streptomyces tacrolimicus: effect on sporulation and tacrolimus biosynthesis. |
2011 |
Appl. Microbiol. Biotechnol. |
pmid:21792593
|
Ma D et al. |
Manipulating the expression of SARP family regulator BulZ and its target gene product to increase tacrolimus production. |
2018 |
Appl. Microbiol. Biotechnol. |
pmid:29666890
|
Ordóñez-Robles M et al. |
Streptomyces tsukubaensis as a new model for carbon repression: transcriptomic response to tacrolimus repressing carbon sources. |
2017 |
Appl. Microbiol. Biotechnol. |
pmid:28983826
|
Kim DH et al. |
Mutational biosynthesis of tacrolimus analogues by fkbO deletion mutant of Streptomyces sp. KCTC 11604BP. |
2013 |
Appl. Microbiol. Biotechnol. |
pmid:23392766
|
MartÃnez-Castro M et al. |
Taxonomy and chemically semi-defined media for the analysis of the tacrolimus producer 'Streptomyces tsukubaensis'. |
2013 |
Appl. Microbiol. Biotechnol. |
pmid:22990582
|
Chen D et al. |
Improvement of FK506 production in Streptomyces tsukubaensis by genetic enhancement of the supply of unusual polyketide extender units via utilization of two distinct site-specific recombination systems. |
2012 |
Appl. Environ. Microbiol. |
pmid:22582065
|
Mo S et al. |
Roles of fkbN in positive regulation and tcs7 in negative regulation of FK506 biosynthesis in Streptomyces sp. strain KCTC 11604BP. |
2012 |
Appl. Environ. Microbiol. |
pmid:22267670
|
Kallscheuer N et al. |
Single-Domain Peptidyl-Prolyl cis/trans Isomerase FkpA from Corynebacterium glutamicum Improves the Biomass Yield at Increased Growth Temperatures. |
2015 |
Appl. Environ. Microbiol. |
pmid:26341203
|
Kuo WW et al. |
Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II. |
2006 |
Apoptosis |
pmid:16699953
|
Rapak A et al. |
Apoptosis of lymphoma cells is abolished due to blockade of cytochrome c release despite Nur77 mitochondrial targeting. |
2007 |
Apoptosis |
pmid:17701362
|
Kabat-Koperska J et al. |
The influence of exposure to immunosuppressive treatment during pregnancy on renal function and rate of apoptosis in native kidneys of female Wistar rats. |
2016 |
Apoptosis |
pmid:27586504
|
Kemper K et al. |
Targeting colorectal cancer stem cells with inducible caspase-9. |
2012 |
Apoptosis |
pmid:22223359
|
Ginestà MM et al. |
Acute xenograft rejection, late xenograft rejection and long term survival xenografts in the hamster-to-rat heart transplantation model: histological characterisation under low-dose of FK506. |
2002 |
APMIS |
pmid:12583441
|
Pea F et al. |
Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients. |
2008 |
Antivir. Ther. (Lond.) |
pmid:18771060
|
Gauthier C et al. |
Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12709320
|
Del Poeta M et al. |
Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10681348
|
Steinbach WJ et al. |
Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17502415
|
Gao L et al. |
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923863
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Steinbach WJ et al. |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15105118
|
Onyewu C et al. |
Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17664323
|
Lamoth F et al. |
In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23165466
|
Onyewu C et al. |
Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604527
|
Fortwendel JR et al. |
Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19015336
|
Lamping E et al. |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19015352
|
Reedy JL et al. |
Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16569889
|
Katiyar SK et al. |
Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance. |
2012 |
Antimicrob. Agents Chemother. |
pmid:23027185
|
Vaes M et al. |
Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome. |
2012 |
Antimicrob. Agents Chemother. |
pmid:23027198
|
Morikawa K et al. |
Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7509146
|
Zhuang D et al. |
Effect of calcineurin inhibitors on posaconazole blood levels as measured by the MVista microbiological assay. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18025114
|
Sun S et al. |
In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18056277
|
Kontoyiannis DP et al. |
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18070977
|
Hashemizadeh Z et al. |
Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923870
|
Ricardo E et al. |
In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24867987
|
Coilly A et al. |
Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22908172
|
Gao L and Sun Y |
In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26303797
|
Uppuluri P et al. |
Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18180354
|
Odom A et al. |
The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. |
1997 |
Antimicrob. Agents Chemother. |
pmid:8980772
|
Roy J et al. |
The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384349
|
Steinbach WJ et al. |
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561883
|
Sugita T et al. |
A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16870799
|
Dang W et al. |
Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28807916
|
Aoki Y and Kao PN |
Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543746
|
Dannaoui E et al. |
In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19451295
|
Rivosecchi RM et al. |
Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28674051
|
Rosenwirth B et al. |
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7527198
|
Venkataramanan R et al. |
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12183280
|
Mizuno K et al. |
Modulation of multidrug resistance by immunosuppressive agents: cyclosporin analogues, FK506 and mizoribine. |
1992 Jan-Feb |
Anticancer Res. |
pmid:1373592
|
Pinsk V et al. |
Complete Reversion of Familial Adenomatous Polyposis Phenotype Associated with Tacrolimus and Mycophenolate Mofetil Treatment Following Kidney Transplantation. |
2017 |
Anticancer Res. |
pmid:28551651
|
Kalas W et al. |
FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand. |
2003 Mar-Apr |
Anticancer Res. |
pmid:12820430
|
Harada N et al. |
Serum Asunaprevir and Daclatasvir Concentrations and Outcomes in Patients with Recurrent Hepatitis C Who Have Undergone Living Donor Liver Transplantation. |
2018 |
Anticancer Res. |
pmid:30194210
|
Ling G et al. |
Mycophenolate Mofetil Alone and in Combination with Tacrolimus Inhibits the Proliferation of HT-29 Human Colonic Adenocarcinoma Cell Line and Might Interfere with Colonic Tumorigenesis. |
2018 |
Anticancer Res. |
pmid:29848681
|
Morisaki T et al. |
A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells. |
2000 Sep- Oct |
Anticancer Res. |
pmid:11131636
|
Gornet JM et al. |
Severe CPT-11-induced diarrhea in presence of FK-506 following liver transplantation for hepatocellular carcinoma. |
2001 Nov-Dec |
Anticancer Res. |
pmid:11911319
|
Jachez B et al. |
Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives. |
1993 |
Anticancer Drugs |
pmid:7683935
|
Yamamoto M et al. |
Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. |
1995 |
Anticancer Drugs |
pmid:7579561
|
Pourtier-Manzanedo A et al. |
FK-506 (fujimycin) reverses the multidrug resistance of tumor cells in vitro. |
1991 |
Anticancer Drugs |
pmid:1724925
|
Epand RF and Epand RM |
The new potent immunosuppressant FK-506 reverses multidrug resistance in Chinese hamster ovary cells. |
1991 |
Anticancer Drug Des. |
pmid:1714737
|
Romano S et al. |
FK506 binding proteins as targets in anticancer therapy. |
2010 |
Anticancer Agents Med Chem |
pmid:21182472
|
Nikitin AV |
[Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors]. |
2014 |
Antibiot. Khimioter. |
pmid:25051716
|
Pratt WB |
The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. |
1997 |
Annu. Rev. Pharmacol. Toxicol. |
pmid:9131255
|
Tzakis AG et al. |
Intestinal transplantation. |
1994 |
Annu. Rev. Med. |
pmid:7515221
|
Hanauer SB and Dassopoulos T |
Evolving treatment strategies for inflammatory bowel disease. |
2001 |
Annu. Rev. Med. |
pmid:11160781
|
Sigal NH and Dumont FJ |
Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. |
1992 |
Annu. Rev. Immunol. |
pmid:1375473
|
Schmid FX |
Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions. |
1993 |
Annu Rev Biophys Biomol Struct |
pmid:7688608
|
Holechek MJ |
Medication review: FK 506. |
1991 |
ANNA J |
pmid:1708982
|
Aguiar D et al. |
Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients. |
2017 |
Ann. Transplant. |
pmid:28461684
|
Gardiner KM et al. |
Multinational Evaluation of Mycophenolic Acid, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus Utilization. |
2016 |
Ann. Transplant. |
pmid:26729299
|
Tang JT et al. |
A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients. |
2018 |
Ann. Transplant. |
pmid:29735966
|
Abdel Halim M et al. |
Toxic tacrolimus blood levels with rifampin administration in a renal transplant recipient. |
2010 Jan-Mar |
Ann. Transplant. |
pmid:20305320
|
Malinowski M et al. |
The influence of commonly used immunosuppressive drugs on the small bowel functions - a comparative experimental study. |
2009 Apr-Jun |
Ann. Transplant. |
pmid:19487793
|